Marijuana For Sale

Despite a massive slowdown in cannabis funding and stock price growth, with many of the largest players within the space largely under-performing the wider market, trading remains hot. During the last two years, the marijuana industry has seen greater than $26 billion in funding deals and M&A.

Beyond the figures, marijuana-related companies have really reached the mainstream, with several big ETFs trading on major stock exchanges. And this includes, the following trade on the NYSE: the ETFMG Alternative Harvest ETF (NYSE: MJ), the AdvisorShares Pure Cannabis ETF (NYSE: YOLO), the Cannabis ETF (NYSE: THCX), as well as the Amplify Seymour Cannabis ETF (NYSE: CNBS).

Further evidencing the mainstreaming of cannabis are brands like weed grower Cronos Group Inc. (NASDAQ: CRON) and cannabinoid-based biotech GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) listing in the Nasdaq, Canopy Growth (NYSE: CGC) trading in the NYSE, and Acreage Holdings (OTC: ACRZF) going after Super Bowl ads and getting political big guns like John Boehner and Bill Weld aboard as advisors.

we make an effort to keep readers up-to-date with the most recent news, stock picks, and expert commentary. But, while we continue to obtain the question about how you can invest in marijuana stocks, we’ve chose to put a quick guide together to suit your needs. Before moving on, it’s necessary for readers to understand that purchasing cannabis is not really confined to growers or retailers.

There are numerous companies providing ancillary services for the industry, as well as many derivative plays, like pharma and biotech companies making cannabinoid-based drugs and repair/product suppliers that employed to operate outside the marijuana industry but have gotten aboard since legalization.

The Over-the-Counter Issue – While multiple states within the U.S. have legalized cannabis for either recreational or medical uses, allowing companies to thrive, the plant remains illegal over a Federal level – classified as a Schedule I drug by the DEA. It has managed to make it challenging for a lot of companies to obtain listed on the Nasdaq or perhaps the NYSE.

Seeking alternative avenues to increase capital, many businesses go public in Canadian exchanges, while others have done so by trading on over-the-counter U.S. exchanges. This means that many publicly traded cannabis companies are certainly not subject to the identical amount of scrutiny that major exchanges and the SEC impose – although those trading in the TSX and CSE are susceptible to heavy scrutiny.

“The over-the-counter exchanges present challenges. They’re not taken as seriously as the bigger exchanges, and in addition they allow for a better amount of latitude in terms of the quality of the company which will trade upon them. Consequently, lots of the companies (…) who have something to do with cannabis probably shouldn’t be there. They got there because entrepreneurs think it is the only way they might obtain access to capital; there was somebody that had a publicly traded vehicle that appeared like it zhzvmn be considered a good fit,” Leslie Bocskor, investment banker and President of cannabis advisory firm Electrum Partners, told Benzinga.

Having said this, he added that not every OTC or penny stock is going to be avoided at all costs. “There is actually a prejudice against low priced stocks i think we require to get away from as being an industry and start looking towards reverse splitting our stocks, having fewer numbers of shares and better prices since the optics on it are better,” Bocskor voiced.

Weed Store..

We are using cookies on our website

Please confirm, if you accept our tracking cookies. You can also decline the tracking, so you can continue to visit our website without any data sent to third party services.